Novel Treatment For Glioblastoma Disease Developed By This Company

IN8bio's INB-200 Shows Promising Results for Glioblastoma Patients: What It Means for You.

In the world of medical research, breakthroughs are often incremental, each new discovery building upon the last. But every so often, a development comes along that has the potential to fundamentally change the way we approach a disease. IN8bio (NASDAQ: $INAB) unveiled such a development recently with INB-200, a novel treatment for glioblastoma, a parti…